Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 2

D6. New diagnostics (formerly L2)

Session: Late Breaker Abstracts

LB17 - Immunosequencing of the T-Cell Receptor Repertoire Reveals Signatures Specific for Diagnosis and Characterization of Early Lyme Disease

Saturday, October 2, 2021
1:15 PM - 3:00 PM EDT
Participants should be aware of the following financial/non-financial relationships:
Sudeb C. Dalai, MD, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Julia Greissl, PhD: Microsoft (Employee, Shareholder)
Mitch Pesesky, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Allison W. Rebman, MPH: Global Lyme Alliance (Research Grant or Support)Steven and Alexandra Cohen Foundation (Research Grant or Support)
Mark J. Soloski, PhD: NIH grant P30 AR070254 (Grant/Research Support)Steven and Alexandra Cohen Foundation (Research Grant or Support)
Elizabeth J. Horn, PhD: Adaptive Biotechnologies (Research Grant or Support)Bay Area Lyme Foundation (Research Grant or Support)Lyme Disease Biobank (Employee)Steven and Alexandra Cohen Foundation (Research Grant or Support)
Jennifer N. Dines, MD: Adaptive Biotechnologies (Employee, Shareholder)
Rachel M. Gittelman, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Thomas M. Snyder, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Ryan O. Emerson, PhD: Adaptive Biotechnologies (Other Financial or Material Support, Employment with Adaptive Biotechnologies during the time of this study)
Edward Meeds, PhD: Microsoft (Employee, Shareholder)
Thomas Manley, MD: Adaptive Biotechnologies (Other Financial or Material Support, Declares employment with Adaptive Biotechnologies during the time of this study)
Ian M. Kaplan, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Lance Baldo, MD: Adaptive Biotechnologies (Employee, Shareholder, Leadership Interest)
Jonathan M. Carlson, PhD: Microsoft (Employee, Shareholder)
Harlan S. Robins, PhD: Adaptive Biotechnologies (Board Member, Employee, Shareholder)
John Aucott, MD: Adaptive Biotechnologies (Advisor or Review Panel member)Bay Area Lyme Foundation (Other Financial or Material Support, Scientific Advisory Board member)Department of Health and Human Services (Other Financial or Material Support, Past Chair, 2018, HHS Tick-borne Disease Working Group, Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary of Health)Expert testimony (Other Financial or Material Support, Expert testimony)Global Lyme Alliance (Research Grant or Support)Pfizer (Consultant)Steven and Alexandra Cohen Foundation (Research Grant or Support)Tarsus Pharmaceuticals (Consultant)

    Co-Author(s)

  • JG

    Julia Greissl, PhD

    Microsoft Research
    Redmond, Washington, United States

    Microsoft (Employee, Shareholder)

  • MP

    Mitch Pesesky, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • Sudeb C. Dalai, MD, PhD

    Senior Medical Director
    Adaptive Biotechnologies and Stanford University School of Medicine
    Seattle, WA, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • AR

    Allison W. Rebman, MPH

    Johns Hopkins University School of Medicine
    Baltimore, Maryland, United States

    Global Lyme Alliance (Research Grant or Support)Steven and Alexandra Cohen Foundation (Research Grant or Support)

  • MS

    Mark J. Soloski, PhD

    Johns Hopkins University School of Medicine
    Baltimore, Maryland, United States

    NIH grant P30 AR070254 (Grant/Research Support)Steven and Alexandra Cohen Foundation (Research Grant or Support)

  • EH

    Elizabeth J. Horn, PhD

    Lyme Disease Biobank
    Portland, Oregon, United States

    Adaptive Biotechnologies (Research Grant or Support)Bay Area Lyme Foundation (Research Grant or Support)Lyme Disease Biobank (Employee)Steven and Alexandra Cohen Foundation (Research Grant or Support)

  • JD

    Jennifer N. Dines, MD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • RG

    Rachel M. Gittelman, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • Thomas M. Snyder, PhD

    VP, Research
    Adaptive Biotechnologies
    Seattle, WA, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • RE

    Ryan O. Emerson, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Other Financial or Material Support, Employment with Adaptive Biotechnologies during the time of this study)

  • EM

    Edward Meeds, PhD

    Microsoft Research
    Cambridge, England, United Kingdom

    Microsoft (Employee, Shareholder)

  • TM

    Thomas Manley, MD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Other Financial or Material Support, Declares employment with Adaptive Biotechnologies during the time of this study)

  • IK

    Ian M. Kaplan, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • LB

    Lance Baldo, MD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder, Leadership Interest)

  • JC

    Jonathan M. Carlson, PhD

    Microsoft Research
    Redmond, Washington, United States

    Microsoft (Employee, Shareholder)

  • HR

    Harlan S. Robins, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Board Member, Employee, Shareholder)

    • Presenting Author(s)

  • John Aucott, MD

    Associate Professor of Medicine
    Johns Hopkins University School of Medicine
    Baltimore, MD, United States

    Adaptive Biotechnologies (Advisor or Review Panel member)Bay Area Lyme Foundation (Other Financial or Material Support, Scientific Advisory Board member)Department of Health and Human Services (Other Financial or Material Support, Past Chair, 2018, HHS Tick-borne Disease Working Group, Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary of Health)Expert testimony (Other Financial or Material Support, Expert testimony)Global Lyme Alliance (Research Grant or Support)Pfizer (Consultant)Steven and Alexandra Cohen Foundation (Research Grant or Support)Tarsus Pharmaceuticals (Consultant)